Both in Pharmaceuticals
ArriVent BioPharma vs Phibro Animal Health
Over the past year AVBP returned +62.7% and PAHC returned −9.5%; their daily moves had a correlation of 0.06.
AVBP +62.7% PAHC −9.5%Growth of $1, one year, split-adjusted
| Metric | AVBP | PAHC |
|---|---|---|
| Price | $29.54 | $35.45 |
| Market cap | $1.46B | $1.44B |
| Today | +0.82% | −0.70% |
| 1 month | −2.1% | −5.9% |
| 6 months | +40.6% | −33.6% |
| Year to date | +46.8% | −5.1% |
| 1 year | +63.8% | −8.7% |
| Revenue growth (YoY) | — | +4.8% |
| Gross margin | — | 33.9% |
| Net margin | — | 5.5% |
| P/E (TTM) | — | 14.4× |
| Price / sales | — | 0.9× |
| Net cash | $373.1M | -$650.8M |
| Dividend yield | — | 1.35% |
| Volatility (60d) | 54.5% | 31.2% |
| Short % of float | 28.0% | 5.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).